Effective January 22, 2015, Cubist Pharmaceuticals is now a wholly owned subsidiary of Merck & Co., Inc.

Every day, our experts search for new discoveries and push scientific boundaries in our efforts to deliver powerful medicines for some of the greatest medical challenges.  More 

12/19/2014 - Cubist Announces FDA Approval of New Antibiotic ZERBAXA™ (Ceftolozane/Tazobactam) for Complicated Urinary Tract and Complicated Intra-abdominal Infections 
 

At Cubist, our culture is our foundation. We share a passion for learning, collaborating, innovating, and most of all, making a difference in people’s lives.  
More